Zargis Medical Awarded Fundamental New Patent
26 October 2005 - 11:00PM
PR Newswire (US)
PRINCETON, N.J., Oct. 26 /PRNewswire/ -- Zargis Medical Corp., a
majority-owned subsidiary of Speedus Corp. (NASDAQ:SPDE) and
developer of computer-aided medical devices, today announced that
its portfolio of intellectual property has been broadened following
the issuance of a fundamental new patent. The patent-number
6,953,436-was issued on October 11, 2005. The patent is entitled
"Multi-modal cardiac diagnostic decision support system and
method", and expands Zargis' extensive portfolio of protected
technologies by describing a method of extracting and evaluating
features from cardiac acoustic signals and a means for determining
whether or not the sounds are innocent or indicative of disease
based on expert rules. Among other things, the inventions covered
by this patent could aid a physician in detecting valvular heart
diseases that might otherwise go undiagnosed, discriminating
pathological from innocent heart murmurs and making better patient
referral decisions while documenting the basis for the decision.
"Ingenuity and creativity are cornerstones of the Zargis
organization and culture. We continue to make significant
investments in the enhancement of our diagnostic algorithms and the
expansion of our patent portfolio with the firm belief that our
computer-aided auscultation technology will become a new standard
in healthcare," commented John Kallassy, Zargis' CEO. Zargis
currently controls 12 patents and patent applications. About Zargis
Medical Corp. Zargis Medical Corp. develops advanced diagnostic
decision support products and services for primary care physicians,
pediatricians, cardiologists and other healthcare professionals.
Zargis was formed in 2001 when Siemens Corporate Research, a
division of Siemens AG (NYSE:SI), and Speedus Corp. co-invested to
develop and market an advanced acoustic technology designed to
detect heart abnormalities identified through analysis of heart
sounds. About Speedus Corp. Speedus Corp. is a holding company with
controlling interests in Zargis Medical Corp. and F&B Gudtfood
Holdings, Inc. Speedus Corp. also owns broadband intellectual
property and controls licensed wireless frequencies. For additional
information about Zargis Medical or Speedus Corp., visit the
following Web sites: http://www.zargis.com/ and
http://www.speedus.com/. Statements contained herein that are not
historical facts, including but not limited to statements about the
Company's product, corporate identity and focus, may be
forward-looking statements that are subject to a variety of risks
and uncertainties. There are a number of important factors that
could cause actual results to differ materially from those
expressed in any forward- looking statements made by the Company,
including, but not limited to, the continuing development of the
Company's sales, marketing and support efforts. DATASOURCE: Zargis
Medical Corp. CONTACT: Peter Hodge, +1-203-829-1348, , for Zargis
Medical Corp. Web site: http://www.speedus.com/
http://www.zargis.com/
Copyright
Speedus (CE) (USOTC:SPDE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Speedus (CE) (USOTC:SPDE)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Speedus Corp (CE) (OTCMarkets): 0 recent articles
More Speedus (MM) News Articles